U.S. coronavirus response still crippled by lack of testing, Dr. Scott Gottlieb says

As coronavirus outbreaks continue to grow across a number of states, the U.S. response is still hampered by a lack of testing and an inability to direct resources to so-called hot spots, former Food and Drug Administration Commissioner Dr. Scott Gottlieb told CNBC on Monday.

Nationally, the U.S. has ramped up testing from an average of just over 174,000 diagnostic tests per day through Ap...

Continue reading
Coronavirus live updates: Danaher antibody test gets emergency approval; Gilead announces remdesivir pricing

Zoom In IconArrows pointing outwards

New cases of the coronavirus continued to surge over the weekend across several U.S. states, mostly in the American South and West. Amid the rise in new cases, Health and Human Services Secretary Alex Azar warned Sunday that the "window is closing" to curb the spread of the virus and get the outbreak under control.

This is CNBC's l...

Continue reading
Burger King's U.S. same-store sales are flat as fast-food customers return to restaurants

Burger King's U.S. same-store sales are trending flat as customers return to its locations for Whoppers and french fries. 

The Restaurant Brands International chain saw its same-store sales plunge by the mid-30s in March as the coronavirus pandemic led consumers to stay home and cook. But now, even with many of its North American dining rooms closed or offering only reduced seating, ...

Continue reading
Gilead's coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance

Gilead Sciences announced Monday the much-anticipated pricing for its coronavirus treatment remdesivir, saying it will cost hospitals $3,120 for a typical U.S. patient with commercial insurance.

The company announced its pricing plans in preparation for it to begin charging for the antiviral drug in July. The company has been donating doses to the U.S. government for distribution since it...

Continue reading
CEO of major hospital in epicenter of Texas' coronavirus surge issues a warning to young adults

The CEO of a Houston-area hospital system told CNBC on Monday that Texas' spike in coronavirus cases is impacting a greater number of people under 50 than earlier in the pandemic. 

"We are definitely seeing this affect young people, and they're getting quite ill," Houston Methodist CEO Dr. Marc Boom said on "Squawk Box." "So we really need everybody to d...

Continue reading